VCYT - Veracyte Inc
IEX Last Trade
31.56
-0.380 -1.204%
Share volume: 676,769
Last Updated: Fri 30 Aug 2024 09:59:58 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$31.94
-0.38
-1.19%
View ratios
Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
---|---|---|---|---|---|---|---|---|---|
Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
Report Date | 2022-08-03 | 2022-11-03 | 2023-03-01 | 2023-05-05 | 2023-08-09 | 2023-11-08 | 2024-02-29 | 2024-05-08 | |
Total revenue | 72.864 M | 75.592 M | 80.297 M | 82.422 M | 90.322 M | 90.108 M | 98.199 M | 96.844 M | |
Cost of revenue | 25.030 M | 26.008 M | 26.831 M | 26.229 M | 29.688 M | 27.610 M | 29.376 M | 31.461 M | |
Gross profit | 47.834 M | 49.584 M | 53.466 M | 56.193 M | 60.634 M | 62.498 M | 68.823 M | 65.383 M | |
3.66% | 7.83% | 5.10% | 7.90% | 3.07% | 10.12% | -5.00% | |||
Operating expenses | 53.176 M | 54.051 M | 53.622 M | 61.362 M | 63.344 M | 54.000 M | 66.318 M | 65.957 M | |
Selling general and admin | 43.799 M | 43.278 M | 42.335 M | 48.593 M | 50.803 M | 40.678 M | 47.645 M | 49.992 M | |
Research and development | 9.377 M | 10.773 M | 11.287 M | 12.769 M | 12.541 M | 13.322 M | 18.673 M | 15.965 M | |
Total expenses | 83.597 M | 85.272 M | 85.717 M | 92.920 M | 98.373 M | 86.947 M | 100.257 M | 101.071 M | |
2.00% | 0.52% | 8.40% | 5.87% | -11.61% | 15.31% | 0.81% | |||
Operating income | -10.733 M | -9.680 M | -5.420 M | -10.498 M | -8.051 M | 3.161 M | -2.058 M | -4.227 M | |
Ebit | -10.733 M | -9.680 M | -5.420 M | -10.498 M | -8.051 M | 3.161 M | -2.058 M | -4.227 M | |
Pretax income | -9.647 M | -8.875 M | -3.441 M | -8.091 M | -8.277 M | -29.772 M | -30.472 M | -1.908 M | |
-8.00% | -61.23% | 135.14% | 2.30% | 259.70% | 2.35% | -93.74% | |||
Income tax | -115.000 K | -152.000 K | 403.000 K | 0.000 | 125.000 K | -154.000 K | -2.179 M | -44.000 K | |
Net income basic | -9.532 M | -8.723 M | -3.844 M | -8.091 M | -8.402 M | -29.618 M | -28.293 M | -1.864 M | |
8.49% | 55.93% | -110.48% | -3.84% | -252.51% | 4.47% | 93.41% | |||
Net income | -9.532 M | -8.723 M | -3.844 M | -8.091 M | -8.402 M | -29.618 M | -28.293 M | -1.864 M | |
8.49% | 55.93% | -110.48% | -3.84% | -252.51% | 4.47% | 93.41% |